Literature DB >> 15793126

Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism.

L V Baker1, T J Brown, O Maxwell, A L Gibson, Z Fang, M D Yates, F A Drobniewski.   

Abstract

The present study investigated the prevalence and diagnostic potential of the most commonly reported mutations associated with isoniazid resistance, katG 315Thr, katG 315Asn, inhA -15T, inhA -8A, and the oxyR-ahpC intergenic region, in a population sample of 202 isoniazid-resistant Mycobacterium tuberculosis isolates and 176 randomly selected fully sensitive isolates from England and Wales identified by using a directed oligonucleotide array and limited DNA sequencing. The strains were recovered from patients originating from 29 countries; 41 isolates were multidrug resistant. Mutations affecting katG 315, the inhA promoter, and the oxyR-ahpC intergenic region were found in 62.7, 21.9, and 30% of 169 genotypically distinct isoniazid-resistant isolates, respectively, whereas they were found in 0, 0, and 8% of susceptible strains, respectively. The frequency of mutation at each locus was unrelated to the resistance profile or previous antituberculous drug therapy. The commonest mutation in the oxyR-ahpC intergenic region, ahpC -46A, was present in 23.7% of isoniazid-resistant isolates and 7.5% of susceptible isolates. This proved to be a phylogenetic marker for a subgroup of M. tuberculosis strains originating on the Indian subcontinent, which shared IS6110-based restriction fragment length polymorphism and spoligotype features with the Delhi strain and Central Asian strain CAS1; and this marker is strongly associated with isoniazid resistance and the katG 315Thr mutation. In total, 82.8% of unrelated isoniazid-resistant isolates could be identified by analysis of just two loci: katG 315 and the inhA promoter. Analysis of the oxyR-ahpC intergenic region, although phylogenetically interesting, does not contribute significantly to further identification of isoniazid-resistant isolates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793126      PMCID: PMC1068606          DOI: 10.1128/AAC.49.4.1455-1464.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  54 in total

Review 1.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

2.  Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis.

Authors:  H Rinder; A Thomschke; S Rüsch-Gerdes; G Bretzel; K Feldmann; M Rifai; T Löscher
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-07       Impact factor: 3.267

3.  A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia.

Authors:  H J Marttila; H Soini; E Eerola; E Vyshnevskaya; B I Vyshnevskiy; T F Otten; A V Vasilyef; M K Viljanen
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

4.  Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands.

Authors:  D van Soolingen; P E de Haas; H R van Doorn; E Kuijper; H Rinder; M W Borgdorff
Journal:  J Infect Dis       Date:  2000-10-26       Impact factor: 5.226

5.  Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis.

Authors:  B Heym; E Stavropoulos; N Honoré; P Domenech; B Saint-Joanis; T M Wilson; D M Collins; M J Colston; S T Cole
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

6.  Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance.

Authors:  D A Rouse; J A DeVito; Z Li; H Byer; S L Morris
Journal:  Mol Microbiol       Date:  1996-11       Impact factor: 3.501

7.  Global distribution of Mycobacterium tuberculosis spoligotypes.

Authors:  Ingrid Filliol; Jeffrey R Driscoll; Dick Van Soolingen; Barry N Kreiswirth; Kristin Kremer; Georges Valétudie; Dang Duc Anh; Rachael Barlow; Dilip Banerjee; Pablo J Bifani; Karine Brudey; Angel Cataldi; Robert C Cooksey; Debby V Cousins; Jeremy W Dale; Odir A Dellagostin; Francis Drobniewski; Guido Engelmann; Séverine Ferdinand; Deborah Gascoyne-Binzi; Max Gordon; M Cristina Gutierrez; Walter H Haas; Herre Heersma; Gunilla Källenius; Eric Kassa-Kelembho; Tuija Koivula; Ho Minh Ly; Athanasios Makristathis; Caterina Mammina; Gerald Martin; Peter Moström; Igor Mokrousov; Valérie Narbonne; Olga Narvskaya; Antonino Nastasi; Sara Ngo Niobe-Eyangoh; Jean W Pape; Voahangy Rasolofo-Razanamparany; Malin Ridell; M Lucia Rossetti; Fritz Stauffer; Philip N Suffys; Howard Takiff; Jeanne Texier-Maugein; Véronique Vincent; Jacobus H De Waard; Christophe Sola; Nalin Rastogi
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

8.  Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia.

Authors:  D van Soolingen; L Qian; P E de Haas; J T Douglas; H Traore; F Portaels; H Z Qing; D Enkhsaikan; P Nymadawa; J D van Embden
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Predominace of a novel Mycobacterium tuberculosis genotype in the Delhi region of India.

Authors:  N Vijaya Bhanu; D van Soolingen; J D A van Embden; L Dar; R M Pandey; P Seth
Journal:  Tuberculosis (Edinb)       Date:  2002       Impact factor: 3.131

10.  The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.

Authors:  Y Zhang; B Heym; B Allen; D Young; S Cole
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

View more
  24 in total

1.  Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study.

Authors:  André L P da Costa; Ivani Pauli; Márcio Dorn; Evelyn K Schroeder; Chang-Guo Zhan; Osmar Norberto de Souza
Journal:  J Mol Model       Date:  2011-08-12       Impact factor: 1.810

2.  Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam.

Authors:  M Caws; Phan Minh Duy; Dau Quang Tho; Nguyen Thi Ngoc Lan; Dai Viet Hoa; Jeremy Farrar
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

3.  Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA.

Authors:  E T Y Leung; P L Ho; K Y Yuen; W L Woo; T H Lam; R Y Kao; W H Seto; W C Yam
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

4.  Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Manzour Hernando Hazbón; Michael Brimacombe; Miriam Bobadilla del Valle; Magali Cavatore; Marta Inírida Guerrero; Mandira Varma-Basil; Helen Billman-Jacobe; Caroline Lavender; Janet Fyfe; Lourdes García-García; Clara Inés León; Mridula Bose; Fernando Chaves; Megan Murray; Kathleen D Eisenach; José Sifuentes-Osornio; M Donald Cave; Alfredo Ponce de León; David Alland
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

5.  Validation of Novel Mycobacterium tuberculosis Isoniazid Resistance Mutations Not Detectable by Common Molecular Tests.

Authors:  Justin L Kandler; Alexandra D Mercante; Tracy L Dalton; Matthew N Ezewudo; Lauren S Cowan; Scott P Burns; Beverly Metchock; Peter Cegielski; James E Posey
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  Seven novel probe systems for real-time PCR provide absolute single-base discrimination, higher signaling, and generic components.

Authors:  James L Murray; Peixu Hu; David A Shafer
Journal:  J Mol Diagn       Date:  2014-11       Impact factor: 5.568

7.  Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia.

Authors:  Caroline Lavender; Maria Globan; Aina Sievers; Helen Billman-Jacobe; Janet Fyfe
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

8.  Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

Authors:  Heidi Albert; Freddie Bwanga; Sheena Mukkada; Barnabas Nyesiga; Julius Patrick Ademun; George Lukyamuzi; Melles Haile; Sven Hoffner; Moses Joloba; Richard O'Brien
Journal:  BMC Infect Dis       Date:  2010-02-26       Impact factor: 3.090

9.  Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Wei-Lun Huang; Huang-Yau Chen; Yuh-Min Kuo; Ruwen Jou
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

10.  Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria.

Authors:  Lana Dinic; Patrick Akande; Emmanuel Oni Idigbe; Agatha Ani; Dan Onwujekwe; Oche Agbaji; Maxwell Akanbi; Rita Nwosu; Bukola Adeniyi; Maureen Wahab; Chindak Lekuk; Chioma Kunle-Ope; Nkiru Nwokoye; Phyllis Kanki
Journal:  J Clin Microbiol       Date:  2012-06-27       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.